Skip to main content
Skip to main content
TCBIO logo

Texas Capital Bancshares, Inc. (TCBIO) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

$19.66 -$0.01 (-0.05%) |Exceptional · 82
Texas Capital Bancshares, Inc. (TCBIO) bottom line: Strongly Bullish — our Council read (76/100) and AI Score (82/100) broadly agree. Strongest signal: Seth Klarman bullish · Biggest watch-out: Momentum weak.Educational signal, not a buy or sell recommendation. Compare sector peers → · Read the method →
MCap: $4.25B| P/E Ratio: 12.81| Vol: 22.5K| 52-wk range: $19.78 – $22.95

P/E 12.81 means the share price is 12.81 times one year of earnings per share; the S&P 500 usually sits near 20-25. Market cap $4.25B is the value of all shares combined. Beta 0.69: the stock has moved about 31% less than the S&P 500.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Texas Capital Bancshares, Inc. (TCBIO) trades at $19.66 with MoonshotScore 82/100 (Grade A+). Texas Capital Bancshares, Inc. is a Texas-based full-service financial services firm catering to businesses, entrepreneurs, and individual customers. Market cap: $4.25B, Sector: Financial services.

Price as of Sep 11, 2026 · Last analyzed: Mar 16, 2026
Texas Capital Bancshares, Inc. is a Texas-based full-service financial services firm catering to businesses, entrepreneurs, and individual customers. The company offers a range of commercial and consumer banking products, investment banking, and wealth management services across major Texan metropolitan areas.

Analyst Coverage for TCBIO: TCBIO does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates TCBIO against Financial Services peers across nine fundamental dimensions and assigns a relatively strong fundamental profile based on the underlying data.

Watch the TCBIO film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Strongly Bullish 76/100 · A

TCBIO: 3/3 scored disciplines lean bullish. Dominant signal: Seth Klarman bullish.

How is this calculated? →
MoonshotScore · Five-pillar engine · 82/100
Business Quality
Moderate Is this a genuinely good business?
Financial Safety
Moderate Could this blow up on me?
Valuation
Strong Am I paying a fair price?
Growth Durability
Strong Is the growth real and likely to last?
Momentum
Weak Is the market already moving on this?

Strongest side: Growth Durability (10/10, Strong). Weakest side: Momentum (2/10, Weak).

Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated)Ray Dalio
Favorable read
Griffin-style lens (simulated)Ken Griffin
Neutral read
Simons-style lens (simulated)Jim Simons
Favorable read
Englander-style lens (simulated)Izzy Englander
Favorable read
Klarman-style lens (simulated)Seth Klarman
Favorable read
Moon AI lens (model)
Favorable read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Moderate
Margin of Safety
Undervalued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

Why this analysis is different

  • A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
  • An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
  • Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Texas Capital Bancshares, Inc. (TCBIO) Financial Services Profile

CEORobert C. Holmes
Employees1,785
HeadquartersDallas, US
IPO Year2021

Texas Capital Bancshares, Inc., operating as Texas Capital Bank, delivers tailored financial solutions in Texas, focusing on commercial and consumer banking, investment banking, and wealth management. With a $4.25B market cap and a P/E ratio of 12.81, the company serves businesses, entrepreneurs, and individuals across major Texan metropolitan areas.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 16, 2026

What Is the Investment Thesis for TCBIO?

AI-written as of Mar 16, 2026 — figures and tone reflect the data available then, not today's score.

The company's focus on commercial and industrial lending, coupled with its wealth management services, caters to a diverse client base. With a market capitalization of $4.25B and a profit margin of 16.5%, TCBIO demonstrates financial stability. Key growth catalysts include expansion within existing Texas markets and strategic investments in technology to enhance customer experience. Potential risks include fluctuations in interest rates and increased competition from larger national banks and fintech companies. The company's beta of 0.69 suggests lower volatility compared to the overall market.

Based on FMP financials and quantitative analysis

TCBIO Key Highlights

AI-written as of Mar 16, 2026 — figures and tone reflect the data available then, not today's score.

Market capitalization of $4.25B, reflecting its position as a regional bank.

  • P/E ratio of 12.81, indicating a potentially undervalued stock compared to its earnings.
  • Profit margin of 16.5%, showcasing its ability to generate profits from its operations.
  • Gross margin of 60.6%, highlighting efficient cost management in its service delivery.
  • Beta of 0.69, suggesting lower volatility compared to the broader market, which may appeal to risk-averse investors.

Who Are TCBIO's Competitors?

TCBIO is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
AMAL Amalgamated Financial Corp. $48.52 +1.44% $1.45B 885-pillar
BHRB Burke & Herbert Financial Services Corp. $71.50 +0.89% $1.44B 945-pillar
DCOM Dime Community Bancshares, Inc. $40.51 +0.30% $1.79B 895-pillar
FMBH First Mid Bancshares, Inc. $50.85 +0.73% $1.35B 815-pillar
FSUN FirstSun Capital Bancorp $40.13 +0.55% $1.88B 845-pillar
UCB United Community Banks, Inc. $35.15 +0.31% $4.21B 925-pillar
CATY Cathay General Bancorp $61.64 -0.64% $4.13B 955-pillar
WSBC WesBanco, Inc. $39.89 -0.89% $3.83B 955-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are TCBIO's Key Strengths?

Strong presence in the growing Texas economy.

  • Diversified revenue streams from banking, investment banking, and wealth management.
  • Experienced management team.
  • Customized service approach and focus on building long-term relationships.

What Are TCBIO's Weaknesses?

Concentration in the Texas market.

  • Smaller size compared to national banks.
  • Dependence on interest rate environment.

What Could Drive TCBIO Stock Higher?

Expansion into new Texas markets, leveraging the state's economic growth.

  • Investments in digital banking platforms to enhance customer experience and operational efficiency.
  • Growth in wealth management services, targeting high-net-worth individuals and families.
  • Strategic acquisitions of smaller regional banks to expand geographic reach and service offerings.

What Are the Key Risks for TCBIO?

Financial-distress signal — its Altman Z-Score of 0.55 sits in the distress zone (elevated bankruptcy risk).

  • Insider selling — insiders were net sellers of roughly $10.7M recently.
  • Increased competition from larger national banks and fintech companies.
  • Economic downturn in Texas, impacting loan growth and asset quality.
  • Changes in interest rates and regulatory environment, affecting profitability.
  • Cybersecurity risks and data breaches, potentially damaging reputation and financial performance.

What Are the Growth Opportunities for TCBIO?

  • Expansion within Existing Texas Markets: Texas Capital Bancshares can capitalize on the robust economic growth in Texas by expanding its presence in existing metropolitan areas like Austin, Dallas, and Houston. The Texas economy is projected to grow at an average rate of 3% annually over the next five years, creating significant opportunities for loan growth and wealth management services. By focusing on deepening relationships with local businesses and entrepreneurs, TCBIO can increase its market share and drive revenue growth. Timeline: Ongoing.
  • Strategic Investments in Technology: Investing in digital banking platforms and fintech solutions can enhance customer experience and improve operational efficiency. The market for digital banking is expected to reach $10 billion by 2028, with a CAGR of 15%. By implementing AI-powered customer service and personalized financial advice, TCBIO can attract and retain customers while reducing costs. This includes mobile banking, online account management, and cybersecurity enhancements. Timeline: Ongoing.
  • Focus on Commercial and Industrial Lending: With a strong foundation in commercial lending, Texas Capital Bancshares can further expand its portfolio by targeting specific industries with high growth potential, such as technology, healthcare, and energy. The demand for commercial loans is expected to increase by 4% annually over the next three years. By offering customized financing solutions and expertise in these sectors, TCBIO can attract new clients and increase its loan volume. Timeline: Ongoing.
  • Wealth Management Services Expansion: Expanding its wealth management services to cater to high-net-worth individuals and families can generate significant fee income. The market for wealth management in Texas is estimated at $500 billion, with a growth rate of 6% annually. By offering personalized investment advice, estate planning, and trust services, TCBIO can attract affluent clients and increase its assets under management. This includes expanding its team of financial advisors and developing new investment products. Timeline: Ongoing.
  • Strategic Acquisitions: Pursuing strategic acquisitions of smaller regional banks or wealth management firms can expand its geographic reach and service offerings. The market for bank acquisitions is expected to remain active, with a focus on consolidation and efficiency gains. By acquiring complementary businesses, TCBIO can increase its scale, diversify its revenue streams, and enhance its competitive position. This includes identifying potential targets with strong local presence and a loyal customer base. Timeline: Ongoing.

What Are TCBIO's Competitive Advantages?

  • Strong local presence and brand recognition in Texas.
  • Customized service approach and focus on building long-term relationships.
  • Expertise in commercial and industrial lending.
  • Diversified revenue streams from banking, investment banking, and wealth management.

What Does TCBIO Do?

Texas Capital Bancshares, Inc., incorporated in 1996 and headquartered in Dallas, Texas, operates as the bank holding company for Texas Capital Bank. It is a full-service financial institution providing customized solutions to businesses, entrepreneurs, and individual customers. The company's services span commercial banking, consumer banking, investment banking, and wealth management. Its commercial banking offerings include business deposit products like commercial checking, lockbox, and cash concentration accounts, alongside advanced online services for information, wire transfers, and account management. Consumer banking includes checking, savings, money market accounts, and certificates of deposit. Texas Capital Bancshares provides commercial loans for various corporate purposes, including working capital, growth, acquisitions, and insurance premiums, as well as consumer loans, energy loans, mortgage finance, and commercial real estate loans. The company also offers equipment finance and leasing, letters of credit, online and mobile banking, debit and credit card services, escrow services, and personal wealth management. Operating in Austin, Fort Worth, Dallas, Houston, and San Antonio, Texas Capital Bancshares serves the major metropolitan areas of Texas, focusing on building strong relationships with its diverse client base.

What Products and Services Does TCBIO Offer?

  • Provides commercial banking services to businesses.
  • Offers consumer banking products, including checking and savings accounts.
  • Delivers investment banking services to corporate clients.
  • Provides wealth management services to individuals and families.
  • Offers commercial loans for various corporate purposes.
  • Provides real estate and construction financing.
  • Offers online and mobile banking solutions.
  • Provides equipment finance and leasing services.

How Does TCBIO Make Money?

  • Generates revenue from interest income on loans.
  • Earns fees from deposit accounts and other banking services.
  • Derives income from investment banking and wealth management activities.
  • Manages risk through diversification of loan portfolio.

What Industry Does TCBIO Operate In?

Texas Capital Bancshares operates within the competitive regional banking sector, characterized by increasing consolidation and technological disruption. The Texas economy, known for its robust growth and diverse industries, provides a favorable environment for regional banks. The industry faces challenges from fintech companies offering innovative financial solutions and larger national banks with greater resources. Texas Capital Bancshares differentiates itself through its customized service approach and focus on building long-term relationships with businesses and entrepreneurs. The regional banking sector is expected to grow at a moderate pace, driven by increasing demand for loans and financial services from small and medium-sized businesses.

Who Are TCBIO's Key Customers?

  • Small and medium-sized businesses in Texas.
  • Entrepreneurs seeking financing and banking services.
  • High-net-worth individuals and families seeking wealth management.
  • Commercial real estate developers and investors.
  • Consumers seeking personal banking services.
Model self-rating on this text: 73% (not a measure of the evidence) Updated: Mar 16, 2026

Research confidence

High 85/100

Broad, current evidence sits behind this analysis.

  • Scored on 100% of our measures
  • Price is current
  • Latest filing 50 days ago
  • No analyst coverage

Why 82?

Measured against companies in the same sector. The figures below are the factor contributions the scoring engine itself produced.

What is helping

  • +0.62 Free cash flow yield (Business Quality)
  • +0.43 Free cash flow yield (Valuation)
  • +0.40 Operating income growth (Growth)

What is holding it back

  • -0.14 6-month price trend (Momentum)
  • -0.10 Distance from the 52-week high (Momentum)
  • -0.09 Volatility vs the market (Financial Strength)

Contribution = how far the company sits from its sector on that measure, weighted by how much the pillar counts. Not investment advice. How the score is built →

MoonshotScore History

Recorded daily since 2026-08-23 · 19 snapshots

2026-08-23 87
2026-08-26 88
2026-08-29 75
2026-09-01 87
2026-09-04 83
2026-09-07 83
2026-09-10 82

What changed?

The grade moved from 87 to 82 (-5).

What moved it up or down:

  • -7 Financial Safety
  • -3 Business Quality
  • -3 Momentum

Held back by:

  • +1 Valuation

Over the same 18 days the stock moved -3.8%.

Texas Capital Bancshares, Inc. Financial Trajectory

Texas Capital Bancshares, Inc. (TCBIO) reported $439.9M in revenue for Q2 FY2026, a decline of 9.9% compared to the prior quarter. The company recorded net income of $84.9M, with diluted EPS of $1.77. Revenue has contracted over three consecutive quarters, which investors in this unknown Financial Services stock should monitor closely. Across the four most recent quarters, TCBIO averaged $1.91 in diluted EPS.

Company Profile

Texas Capital Bancshares, Inc. operates in the Banks - Regional industry within the Financial Services sector. It is headquartered in Dallas, US. The company is led by CEO Robert C. Holmes. TCBIO has traded publicly since 2021.

How Texas Capital Bancshares, Inc. Is Valued

Texas Capital Bancshares, Inc. carries a market capitalization of $4.25B, placing it in the mid-cap category. Relative to its peer group, TCBIO's quantitative score of 82/100 is roughly in line with the peer average of 90/100.

ROE 10%

Key Financial Metrics

Return on equity for Texas Capital Bancshares, Inc. stands at 10.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 1.1%, showing how much profit it generates from its asset base. TCBIO trades at a trailing price-to-earnings ratio of 12.81, below the Financial Services sector average of ~17.50x. Its free cash flow yield is 21.8%, a gauge of the cash the business throws off relative to its market value. A current ratio of 26.12 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 8.3%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 8/9

Financial Health

Texas Capital Bancshares, Inc.'s Piotroski F-Score is 8/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 0.55 places it in the distress zone, a signal of elevated financial risk.

6/7 beats

Earnings Track Record

Texas Capital Bancshares, Inc. has beaten Wall Street's EPS estimate in 6 of its last 7 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 15.7% above estimates on average.

Net selling

Insider Activity

Over the past six months, Texas Capital Bancshares, Inc. insiders filed 30 SEC Form 4 transactions — 13 sales and 17 purchases. On net that is roughly 96K shares disposed (about $10.7M), a signal worth weighing alongside the fundamentals.

TCBIO Financials

Fundamental Snapshot

Revenue Growth (FY)
+13.5%
Net Income Growth (FY)
+326.1%
EPS Growth (FY)
+432.6%
Free Cash Flow Growth (FY)
-16.5%
P/E (TTM)
12.81
Return on Equity (TTM)
+10.0%
Current Ratio
26.1
EV/EBITDA (TTM)
2.6

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Strong presence in the growing Texas economy.
  • Diversified revenue streams from banking, investment banking, and wealth management.
  • Experienced management team.
  • Customized service approach and focus on building long-term relationships.

Bear Case

  • Concentration in the Texas market.
  • Smaller size compared to national banks.
  • Dependence on interest rate environment.
  • Potential: Increased competition from larger national banks and fintech companies.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · September 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q2 FY2026 $440M $85M $1.77
Q1 FY2026 $488M $74M $1.56
Q4 FY2025 $504M $101M $2.12
Q3 FY2025 $529M $105M $2.18

Q2 FY2026 · filed 23 Jul 2026 · SEC EDGAR →

Based on FMP financials and quantitative analysis

TCBIO Latest News

TCBIO Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for TCBIO.

Price Targets

Wall Street price target analysis for TCBIO.

TCBIO MoonshotScore

82/100

What does this score mean?

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. TCBIO scores 82/100 (Grade A+): the number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Leadership: Robert C. Holmes

CEO

Robert C. Holmes serves as the CEO of Texas Capital Bancshares, Inc. His career spans several decades in the financial services industry, with a focus on commercial banking and strategic leadership. Holmes has held various executive positions at leading financial institutions, bringing a wealth of experience in risk management, corporate finance, and business development. His expertise includes navigating complex regulatory environments and driving growth through innovation and customer-centric strategies. Holmes is known for his commitment to fostering a strong corporate culture and building high-performing teams.

Track Record: Under Robert C. Holmes' leadership, Texas Capital Bancshares has focused on strategic growth initiatives and technological advancements. Key achievements include expanding the bank's presence in key Texas markets and enhancing its digital banking capabilities. Holmes has also overseen efforts to strengthen the bank's risk management framework and improve its operational efficiency. His leadership has been instrumental in navigating the challenges of a dynamic economic environment and maintaining the bank's financial stability.

Texas Capital Bancshares, Inc. Financial Services Stock: Key Questions Answered

What does the AI Score mean for TCBIO?

TCBIO holds an AI Score of 82/100 (Grade: A+). This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers. Texas Capital Bancshares, Inc. is a Texas-based full-service financial services firm catering to businesses, entrepreneurs, and individual customers.

Is TCBIO a good stock?

Stock Expert AI does not rate TCBIO buy, sell or hold. Texas Capital Bancshares, Inc. carries a MoonshotScore of 82/100 on the five-pillar engine, a research rating against its peers. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.

What do analysts say about TCBIO stock?

Analyst consensus on TCBIO stock reflects a neutral to positive outlook, considering its strategic positioning in the Texas market and its diversified revenue streams. Key valuation metrics, such as its P/E ratio of 12.81, suggest potential undervaluation compared to its earnings.

What are the key factors to evaluate for TCBIO?

Texas Capital Bancshares, Inc. (TCBIO) holds a MoonshotScore of 82/100 (high). P/E: 12.81x vs the S&P 500's ~20-25x. Not financial advice.

How frequently does TCBIO data refresh on this page?

TCBIO's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven TCBIO's recent stock price performance?

Texas Capital Bancshares, Inc. (TCBIO) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong presence in the growing Texas economy. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider TCBIO overvalued or undervalued right now?

Texas Capital Bancshares, Inc. (TCBIO) trades at 12.81x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of TCBIO?

Yes, most major brokerages offer fractional shares of Texas Capital Bancshares, Inc. (TCBIO) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track TCBIO's earnings and financial reports?

Texas Capital Bancshares, Inc. (TCBIO) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for TCBIO earnings announcements.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated MoonshotScore as of
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • The information provided is based on available data and may be subject to change.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

More Stocks We Cover